Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Naldemedine for opioid-induced constipation in adults with non-malignant chronic pain
2013-002241-11Phase 3Completed
- Sponsor
- Shionogi & Co., Ltd.
- Start
- Oct 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in opioid-induced constipation (OIC) comparing Naldemedine with Placebo (2 arms). Primary endpoint: Proportion of responders. Started Oct 2013; status: completed.
02
Drugs
naldemedine
03
Conditions
opioid-induced constipation (OIC)
Beyond the preview
Go deeper on 2013-002241-11.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2013-002241-11.